GlassScriptPhysician profile
Katelyn Dutkiewicz
NPI 1134368400
$569.73
in general payments reported to CMS, 2019-2025
15 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.85 · 2022: $193 · 2023: $126 · 2024: $31.51 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.28 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $88.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $56.00 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $41.06 | 2021 | |
| Novo Nordisk INC | $36.58 | 2023 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $33.85 | 2025 | |
| Indivior INC. | $24.35 | 2022 | |
| Abbott Laboratories | $23.64 | 2022 | |
| Merck Sharp & Dohme LLC | $22.46 | 2025 | Enflonsia, Capvaxive, M-M-R II |
| Impel Pharmaceuticals INC. | $21.93 | 2023 | Trudhesa |
| Astellas Pharma US INC | $19.68 | 2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $18.15 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.08 | 2023 | Eliquis |
| Pfizer INC. | $13.93 | 2023 | |
| Organon LLC | $12.91 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Dutkiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.